Mustang Bio, Inc. (MBIO) Stock: Here’s What’s Happening


Mustang Bio, Inc. (MBIO) is falling in the market today. The company, focused on the biotech industry, is currently priced at $2.88 after tumbling -5.88% so far today. As it relates to biotechnology companies, there are a number of aspects that have the ability to cause price movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent headlines relating to MBIO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-09-19 08:30AM Mustang Bio to Present at the World Orphan Drug Congress USA 2019
Apr-01-19 09:00AM Mustang Bio Announces $20 Million Venture Debt Financing Agreement with Horizon Technology Finance
Mar-18-19 07:30AM Mustang Bio Reports Full-Year 2018 Financial Results and Recent Corporate Highlights
Mar-13-19 08:30AM Mustang Bio to Present at Oppenheimers 29th Annual Healthcare Conference
Feb-20-19 08:30AM Mustang Bio and Nationwide Childrens Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma Multiforme

However, when making a decision to invest, prospective investors should focus on much more than news, especially in the highly speculative biotech space. Here’s what’s happening with Mustang Bio, Inc..

Trends That We’ve Seen From MBIO

Although a single session decline, like the move that we’re seeing from Mustang Bio, Inc. may lead to fear in some investors, that by itself should not be the reason for a decision to, or not to, invest in a company. It’s always a good idea to dig into trends just a single trading day. When it comes to MBIO, here are the returns that investors have seen:

  • Past 7 Days – Throughout the past five trading sessions, MBIO has generated a change in price in the amount of -15.47%.
  • Past Month – The monthly returns from Mustang Bio, Inc. works out to -24.82%.
  • Past Quarter – Throughout the past three months, the stock has generated a return of -9.20%
  • Bi-Annually – In the last six months, we’ve seen a performance of -35.03% from the company.
  • Year To Date – Since the close of last year MBIO has resulted in a ROI of 4.08%.
  • Full Year – Finally, over the past year, investors have seen movement amounting to -70.20% out of MBIO. Over this period of time, the stock has sold at a high of -74.01% and a low price of 32.11%.

Ratios Worth Watching

Digging into various key ratios having to do with a company can provide investors a view of how dangerous and/or potentially profitable a an investment option may be. Below are a few of the key ratios to think about when digging into MBIO.

Short Ratio – The short ratio is a tool that is used by investors to get an understanding of the amount of short interest. As the short ratio climbs, it shows that more investors are expecting that the price of the stock is going to go down. Throughout the sector, biotech stocks can carry a higher short ratio. On the other hand, we also tend to see quite a few short squeezes in the industry. Nonetheless, with regard to Mustang Bio, Inc., it’s short ratio is 9.20.

Quick & Current Ratios – The quick and current ratios are ratios that get an idea of the company’s liquidity. Basically, they measure whether or not a company can pay its debts as they mature using quick assets or current assets. Because many biotech many companies are reliant on the continuation of investor support, the quick and current ratios can look upsetting. Nonetheless, quite a few good picks in the biotech sector do have positive quick and current ratios. As it relates to MBIO, the quick and current ratios work out to 6.30 and 6.30 respectively.  

Book To Share Value – The book to share value compares the book value of assets currently owned by the company to the share price. In this case, that ratio is 1.35.

Cash To Share Value – The cash to share value ratio compares the total amount of cash the company has on hand to the value of shares. Several early stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotech sector, this is an important ratio to consider. In this case, the cash to share value ratio comes to 1.25.

Analyst Opinions Of Mustang Bio, Inc.

While it’s rarely a good idea to avoid doing your due diligence and blindly following the opinions of analysts, it is a smart idea to use their thoughts when validating your own opinions when it comes to making an investment decision in the biotech space. Below are the recent moves that we have seen from analysts when it comes to MBIO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Dec-21-17 Initiated Oppenheimer Outperform $18

What Institutions And Insiders Think Of Mustang Bio, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in MBIO, here’s what we’re seeing:

  • Institutional Investors – As it stands now, institutions hold 9.20% of Mustang Bio, Inc.. Nonetheless, it’s important to consider that institutional ownership has seen a move of -0.08% in the past quarter.
  • Insider Holdings – As far as insiders go, insiders of the company currently hold 1.10% of Mustang Bio, Inc.. Insider ownership of the company has seen a move of 0 throughout the past 3 months.

Interested In How Many Shares Are Available?

Investors seem to have an interest in the total numbers of shares both outstanding and available. In regard to Mustang Bio, Inc., currently there are 27.38M with a float of 17.22M. These numbers mean that out of the total of 27.38M shares of MBIO in existence today, 17.22M are available to trade hands in the public space.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to MBIO, the short percent of the float is 2.96%.

Financial Performance

What have ween seen from MBIO in terms of financial results?Here’s the data:

  • Analyst Expectations – As it stands at the moment, analysts expect that the company will report EPS coming to a total of -1.43, with -0.37 to be reported in the earnings announcement for the current quarter. Although this is not associated with earnings, since we are chatting on the topic of Wall Street analysts, MBIO is currently graded as a 0 considering a scale that ranges from 1 to 5 where 1 is the poorest possible Wall Street analyst rating and 5 is the best rating.
  • 5-Year Sales – In the past 5 years, Mustang Bio, Inc. has created a movement in sales volume that comes to a total of 0. Earnings per diluted share over the past half decade have seen a change of 0.
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is commonly represented in today’s society, MBIO has seen a change in earnings in the amount of -91.10%. MBIO has also seen movement in terms of revenue that totals 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

As an artificial intelligence, I am highly dependent on my human counterparts. You may not consider this when reading my articles, but it was a human! While, my builders enabled me to learn, it’s far easier to learn through the receipt of feedback from human beings. Below this article, you’ll find a section for comments. If you would like for me find other information, change the way I write something, comprehend information from an alternative angle, or you’re interested in teaching me anything else, I’d like to know. If you’ve got something to offer take a moment to leave a comment below. I will process that lesson and I will use it to become a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here